Pharmaceuticals 2010, 3(4), 1139-1161; doi:10.3390/ph3041139
Review

Lysostaphin: A Staphylococcal Bacteriolysin with Potential Clinical Applications

* email, email and email
Received: 24 March 2010; in revised form: 8 April 2010 / Accepted: 14 April 2010 / Published: 19 April 2010
(This article belongs to the Special Issue Antibiotics)
View Full-Text   |   Download PDF [439 KB, uploaded 19 April 2010]
Abstract: Lysostaphin is an antimicrobial agent belonging to a major class of antimicrobial peptides and proteins known as the bacteriocins. Bacteriocins are bacterial antimicrobial peptides which generally exhibit bactericidal activity against other bacteria. Bacteriocin production is a self-protection mechanism that helps the microorganisms to survive in their natural habitats. Bacteriocins are currently distributed into three main classes. Staphylococcins are bacteriocins produced by staphylococci, which are Gram-positive bacteria of medical and veterinary importance. Lysostaphin is the only class III staphylococcin described so far. It exhibits a high degree of antistaphylococcal bacteriolytic activity, being inactive against bacteria of all other genera. Infections caused by staphylococci continue to be a problem worldwide not only in healthcare environments but also in the community, requiring effective measures for controlling their spread. Since lysostaphin kills human and animal staphylococcal pathogens, it has potential biotechnological applications in the treatment of staphylococcal infections. In vitro and in vivo studies performed with lysostaphin have shown that this staphylococcin has potential to be used, solely or in combination with other antibacterial agents, to prevent or treat bacterial staphylococcal infectious diseases.
Keywords: lysostaphin; staphylococci; antimicrobial peptides; bacteriocins; staphylococcins
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Bastos, M.C.F.; Coutinho, B.G.; Coelho, M.L.V. Lysostaphin: A Staphylococcal Bacteriolysin with Potential Clinical Applications. Pharmaceuticals 2010, 3, 1139-1161.

AMA Style

Bastos MCF, Coutinho BG, Coelho MLV. Lysostaphin: A Staphylococcal Bacteriolysin with Potential Clinical Applications. Pharmaceuticals. 2010; 3(4):1139-1161.

Chicago/Turabian Style

Bastos, Maria do Carmo de Freire; Coutinho, Bruna Gonçalves; Coelho, Marcus Lívio Varella. 2010. "Lysostaphin: A Staphylococcal Bacteriolysin with Potential Clinical Applications." Pharmaceuticals 3, no. 4: 1139-1161.


Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert